Excelsior Biopharma Inc. (TPEX:6496)
Taiwan · Delayed Price · Currency is TWD 23.75
0.00 (0.00%)
Oct 20, 2026, 1:30 PM CST
Excelsior Biopharma Market Cap
Excelsior Biopharma has a market cap or net worth of 1.11 billion as of October 20, 2026. It is the 33,103rd most valuable company in the world and the 1,990th biggest in Taiwan. Its market cap has decreased by 20.45% in one year.
Market Cap
1.11B
Enterprise Value
1.49B
Revenue
936.92M
Global Rank
Country Rank
#1,990 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2014, Excelsior Biopharma's market cap has decreased from 2.86B to 1.11B, a decrease of -61.38%. That is a compound annual growth rate of -7.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.11B | -19.09% |
| Dec 31, 2025 | 1.37B | -2.78% |
| Dec 31, 2024 | 1.41B | 3.69% |
| Dec 29, 2023 | 1.36B | 4.50% |
| Dec 30, 2022 | 1.30B | -4.79% |
| Dec 30, 2021 | 1.36B | -1.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.13B |
| Tien Liang BioTech | 1.83B |
| GeneFerm Biotechnology | 1.21B |
| InnoPharmax | 1.13B |
| Anxo Pharmaceutical | 1.07B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 874.13M |
| Mediera | 828.54M |